Assessing value for money in medical screening.
Cairns
J A
JA
Health Economics Research Unit, Department of Public Health, Foresterhill, Aberdeen, United Kingdom.
Shackley
P
P
D003362:Cost-Benefit Analysis; D003550:Cystic Fibrosis / Q000175:diagnosis / Q000517:prevention & control; D004314:Down Syndrome / Q000175:diagnosis / Q000517:prevention & control; D005260:Female; D005820:Genetic Testing / Q000191:economics; D006509:Hepatitis B / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control; D006801:Humans; D008403:Mass Screening / Q000191:economics*; D009436:Neural Tube Defects / Q000175:diagnosis / Q000517:prevention & control; D011247:Pregnancy; D011296:Prenatal Diagnosis / Q000191:economics; D012307:Risk Factors; D006113:United Kingdom